Holmen

Forest revaluation and share buy-back news overshadowed Q2 profitability woes

20/08/19 -"Despite healthy top-line growth, unlike peers, Holmen’s Q2 profitability weakened materially, largely due to sustained issues in Paperboard, and some normalisation and seasonal weakness in Wood ..."

PDF page sample
Pages
49
Language
English
Published on
20/08/19
Download
You may also be interested by these reports :
08/11/19
Ever since mighty Essity (ADD, Sweden) demerged from SCA (ADD, Sweden) in June 2017, it seemed that the former – driven by sacrosanct global ‘health ...
01/11/19
Even though market conditions have become tougher, UPM managed to limit its Q3 business impact via effective cost savings. Interestingly, management ...
31/10/19
As expected, pricing normalisation is gathering momentum across the respective divisions. Yet, SCA’s Q3 profitability exceeded consensus estimates ...
30/10/19
Q3 performance came under (more-than-expected) pressure due to price and volume headwinds across most divisions. The dismal Q4 performance outlook ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO